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Summary 
Neuropeptide-mediated transmission was analyzed at 
Drosophila larval body-wall neuromuscular junctions. 
Focal application of vertebrate pituitary adenylyl cy- 
clase-activating polypeptide (PACAP38) to the neuro- 
muscular junction region triggered two temporally dis- 
tinct muscle responses: an immediate depolarization 
followed by a large enhancement of K ÷ current. This 
late enhancement occurred many minutes after the 
early depolarization. High frequency stimulation of 
motor nerve fibers evoked a postsynaptic response 
mimicking that induced by PACAP38. This evoked re- 
sponse was desensitized by preincubation of the prep- 
aration with PACAP38. PACAP38-1ike immunoreactiv- 
ity was also found in the Drosophila CNS and at almost 
all larval neuromuscular junctions. Moreover, an im- 
munoreactive band that compares well with PACAP38 
in size was identified in Western blot. These results 
demonstrate that a PACAP-like peptide may function 
in invertebrates and that a neuropeptide can evoke two 
distinct postsynaptic responses, each separated by up 
to 15 min. In addition, this initial electrophysiological 
study provides a basis for genetic analysis of neuro- 
peptide function in Drosophila. 
Introduction 
Neuropeptides comprise the largest group of neurotrans- 
mitters in nervous systems (Hokfelt, 1991), so understand- 
ing their actions will likely be a major part in the under- 
standing of neuronal communication. In fact, peptidergic 
systems have been implicated in mechanisms that control 
functions such as stress response, sexual behavior, pain 
perception, and learning and memory (Terenius, 1992; 
Glue et al., 1993; Kovacs and Wied, 1994). A major obsta- 
cle in understanding the mechanistic role of peptidergic 
transmission has been the lack of specific inhibitors 
(Smelik, 1987; Hokfeit, 1991). The powerful genetic and 
molecular techniques available in Drosophila may allow 
mutational perturbation of specific peptide signaling path- 
ways. However, neuropeptide transmission has yet to be 
analyzed electrophysiologically in Drosophila. We have 
begun to search for neuropeptides that function at the 
larval body-wall neuromuscular junctions by immunohis- 
tochemical and electrophysiological nalyses. 
The larval neuromuscular preparation has been exten- 
sively characterized and is suitable for quantitative analy- 
sis of synaptic transmission at identifiable synapses (Jan 
and Jan, 1976a, 1976b, 1978; Wu et al., 1978; Ganetzky 
and Wu, 1983; Johansen et al., 1989; Z.hong and Wu, 
1991a). Glutamate is the major excitatory transmitter at 
this neuromuscular junction (Jan and Jan, 1976b; Jo- 
hansen et al., 1989). In addition, immunoreactivities of the 
neuropeptides proctolin (Anderson et al., 1988), leucoki- 
nin I (Cantera and Nassel, 1992), and insulin (Gorczyca 
et al., 1993) have been observed in nerve terminals in- 
nervating subsets of these muscle fibers. However, the 
electrophysiological function of these peptides remains to 
be established. It is reported in this paper that a vertebrate 
neuropeptide, adenylyl cyclase-activating polypeptide 
(PACAP), and an endogenous Drosophila factor, possibly 
a PACAP-like peptide released upon stimulation of motor 
axons, are both able to trigger a similar novel muscle re- 
sponse. 
PACAP belongs to a neuropeptide family that includes 
vasoactive intestinal peptide (VIP), glucagon, and se- 
cretin (Arimura, 1992). Two bioactive forms of PACAP, 
PACAP38 and PACAP27, are derived from the rat precur- 
sor protein, which consists of 175 amino acid residues 
(Ogi et al., 1990). PACAP27 is an amidated peptide corre- 
sponding to the N-terminal 27 amino acids of PACAP38, 
which itself is 38 amino acids. The peptide sequences are 
identical in humans, rats, and sheep (Arimura, 1992). Two 
types of PACAP receptor have been cloned. Type 1 is 
coupled to both adenytyl cyclase and phospholipase C 
and is specific to PACAP (Spengler et al., 1993). In addi- 
tion, type 1 exhibits a much higher sensitivity to PACAP38 
than to PACAP27 (Spengler et al., 1993). Type 2 is coupled 
to only adenylyl cyclase and is sensitive to both PACAP 
and VIP (Hashimoto, et al., 1993). Both types of receptor 
are distributed widely in vertebrate peripheral tissues and 
in the brain, including the hypothalamus and hippocam- 
pus. PACAP38 and PACAP27 have been reported to regu- 
late hormone or transmitter elease, neurite outgrowth, 
and gene expression (Arimura, 1992; Deutsch and Sun, 
1992; Schadlow et al., 1992; Culler and Paschall, 1991; 
Masuo et al., 1993). 
The presence of PACAP or related neuropeptides 
in invertebrates has not yet been reported. We found 
PACAP38-1ike immunoreactivity in a subset of neurons in 
the Drosophila CNS and at motor nerve terminals that 
innervate larval body-wall muscle fibers. This antibody 
recognizes a peptide with the similar size as PACAP38 in 
Western blot. Furthermore, focal application of PACAP38 
to the neuromuscular junction induces two distinct muscle 
responses at separate time windows: an early depolariza- 
tion lasting many seconds and a late, hundred-fold en- 
hancement of K ÷ currents, which starts several minutes 
after the early depolarization and lasts for 2-5 min. A simi- 
lar response can also be evoked by high frequency stimu- 
lation of motor axons, and this evoked response can be 
desensitized by PACAP38. Th us, the present work demon- 
strates that a neuropeptide can trigger two distinct post- 
synaptic responses, each separated by up to 15 min, and 
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Figure 1. PACAP38-1ike Immunoreactivity n 
the Drosophila Larval CNS 
(A) The dorsal view of immunoreactivity of ver- 
tebrate PACAP38 in the ganglion (g) and brain 
lobes (b) of a third instar larva. Arrows point to 
a pair of stained neuronal somas. Inset shows 
focused image of stained cell bodies within 
black square. 
(B) The ventral view of PACAP38 immunoreac- 
tivity in the ventral ganglion. 
(C) The schematic representation f the distri- 
bution of stained cell bodies in the larval CNS. 
Note that comparing the ventral view inthe (C) 
with the pattern ofthe staining in (B) indicates 
that he drawing only approximates the actual 
distribution of the immunoreactivity. 
Bars, 60 llM (A); 30 p.M (B) and inset in (A). 
Results 
PACAP-like Immunoreactivity in the Larval CNS and 
at the Neuromuscular Junction 
Using a vertebrate PACAP38 antiserum, PACAP38-1ike 
immunoreactivity was found in a subset of larval CNS neu- 
rons as well as in motor nerve terminals. This antiserum 
does not cross-react with VIP, PACAP27, or several other 
neuropeptides tested. Figure 1 presents an example that 
shows the distribution of stained cell bodies in the larval 
ventral ganglion and brain lobes. These stained cell bodies 
appear to be distributed primarily in two clearly separated 
focal planes, each plane showing a different pattern as 
revealed in Figure 1A (dorsal view) and Figure 1B (ventral 
view). A schematic presentation of such a distribution is 
depicted in Figure 1C. It should be noted, however, that 
the schematic drawing of the distribution of the stained 
soma in the ventral focal plane (left panel in Figure 1C) 
only roughly approximates the actual situation, owing to 
the complexity of the distribution (Figure 1B). In addition, 
the decay of the labeled fluorescence limits the time for 
detailed observation. Nonetheless, about 320-400 soma 
are strongly stained in the CNS. The categories of the 
stained neurons remain to be determined. The pair of 
soma in each segment hat show the strongest immunore- 
activity (arrows in Figure 1A) send their axons into the 
motor nerve bundles (data not shown), which innervate 
larval body-wall muscle fibers. 
PACAP38-1ike immunoreactivity was found in nerve ter- 
minals innervating almost all muscle fibers. Figure 2A 
shows examples of such immunoreactivity in motor nerve 
terminals arborized on muscle fibers 4, 6, 7, 12, and 13 
(nomenclature of Crossley, 1978). As indicated, the stain- 
ing appears to be concentrated in varicosities where syn- 
aptic vesicles are localized (Jia et al., 1993; Atwood et al., 
1993). A comparison of the patterns of immunoreactivity 
with previous anti-horseradish peroxidase (HRP) staining, 
which reveals all nerve terminals arborized on muscle fi- 
bers (Johansen et al., 1989; Budnik et al., 1990; Zhong 
et al., 1992), suggests that PACAP38-1ike immunoreactiv- 
ity is restricted to large-sized type 1 varicosities and is not 
expressed in small-sized type 2 varicosities. 
PACAP38-1ike immunoreactivity was abolished if the an- 
tiserum was preincubated with 4 pM PACAP38 (Figure 
2B) but was retained if incubated with 4 ~M PACAP27. 
In addition, another anti-PACAP38 antiserum (IHC 8920, 
Peninsula) also produced a similar pattern of immunoreac- 
tivity with much weaker fluorescence (data not shown). 
The two antisera against PACAP27 did not stain the larval 
tissues. These data indicate the specificity of the staining 
to PACAP38. 
PACAP-like Immunoreactivity on Western Blots 
Western blotting was carried out o determine whether 
PACAP38-1ike immunoreactMty identifies a peptide. Faint 
PACAP-like im munoreactivity was detected in total protein 
from Drosophila larvae tissue lysates separated by Tris- 
Tricine polyacrylamide gel electrophoresis (PAGE), blot- 
ted onto Immobilon-P membranes and detected by 
chemiluminescence. When originally isolated, PACAP38 
was purified from several successive ion-exchange chro- 
matography and reverse-phase high pressure liquid chro- 
matography fractions (Miyata et al., 1989). Thus, seeking 
an enrichment of PACAP-like material in Drosophila, we 
employed a similar but simplified crude reverse-phase or- 
ganic extraction in which PACAP38 elutes from C18 high 
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Figure 2. PACAP-like Immunoreactivity at Larval Neuromuscular 
Junctions 
(A) PACAP38-1ike immunoreactivity was found in the motor nerve ter- 
minals on almost all larval body-wall muscle fibers. The representative 
examples of such staining in muscle fibers 4, 6, 7, 12, and 13 are 
shown. Arrows point to stained varicosities where synapses are formed 
(Atwood et al., 1993; Jia et al., 1993). 
(B) PACAP38-1ike immunoreactivity is abolished if antiserum is prein- 
cubated with 4 I~M PACAP38. Examples of muscle fibers 6 and 13 
are presented. 
Bar, 50 I~M. 
pressure liquid chromatography matrix at a specific 
concentration of CH3CN/0.1% trifluoroacetic acid (TFA; 
Tatsuno et al., 1994; Miyata et al., 1989). Under our 
conditions, at a 40% CH3CN/0.1S/o TFA elution, an immu- 
noreactive band of about 5.5 kDa (Figure 3, lanes 1 and 
2) appeared near the position of mouse PACAP38 positive 
control. This compared well with the PACAP38 peptide 
employed as a positive control (Figure 3, lane 3). With a 
calculated mass of 4,530 Da, the PACAP38 peptide exhib- 
ited an apparent migration of about 5.4 kDa in this PAGE 
system. In addition to the PACAP38-1ike immunoreactive 
band, a larger immunoreactive band of about 19 kDa was 
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Figure 3. PACAP-like Immunoreactivity on Larval Western Blot 
Chemiluminescent detection of PACAP38-1ike bands from Drosophila 
larvae by anti-PACAP38-1gG. Lanes 1 and 2 show 150 p.g/lane total 
protein recovered in 40% CH3CN fractions eluted from C18 Sep-Pak 
cartridge. Whole larvae tissue homogenized in0.5 M acetic acid (lane 
1) or in high salt, Nonidet P-40 detergent lysis buffer (lane 2). Arrow 
indicates presumed PACAP38-1ike peptide. Lanes 3 and 4 show 25 
ng/lane synthetic vertebrate PACAP38 and PACAP27 peptide, respec- 
tively. At right margin, molecular weight standards in kDa. 
higher molecular weight band was in the range of the 
PACAP precursor protein having a calculated mass of 
19,450 Da (Arimrua, 1992) and therefore may represent 
a possible PACAP precursor polypeptide in Drosophila. 
Only a single PACAP38-1ike immunoreactive band was 
visible in the acetate extract (Figure 3, lane 2). Employed 
as a negative control, PACAP27 peptide was not detect- 
able (Figure 3, lane 4). Similar results were obtained when 
these experiments were done using a crude anti-PACAP38 
antiserum; however, additional higher molecular weight 
bands were evident (data not shown). These results sug- 
gest that antibodies raised against mammalian PACAP38 
indeed identifies a Drosophila polypeptide with a similar 
size as PACAP38 and therefore reinforce the idea about 
the existence of a PACAP38-1ike neuropeptide in Dro- 
sophila. 
PACAP38-1nduced Musc le  Responses  
To determine whether or not such immunoreactivity re- 
flects the presence of a functional neuropeptide similar to 
PACAP38, the effect of focal application of PACAP38 to 
the neuromuscular junction was investigated. In this inves- 
tigation, muscle fiber 6 (n = 14) and muscle fiber 12 (n = 
22) from 24 larvae were examined. Both muscle fibers 6 
and 12 exhibited a similar response. Intracellular re- 
cordings revealed a slow depolarization of 10-20 mV last- 
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Figure 4. PACAP38-1nduced Early Slow Depolarization i  Larval 
Body-Wall Muscles 
(A) Top trace shows the depolarization i duced by local application 
of PACAP38 (4 ~.M). The bar indicates the time at which PACAP38 
was ejected. Middle trace shows a desensitized response following 
the first application (50 s after). Bottom trace shows the recovery of 
the response 5 min after the previous application. 
(B) Application of PACAP38 preincubated with antiserum (15 ~1 of 4 
~M PACAP38 mixed with 4 ILl of 1:40 antiserum) or 10 p.M VIP did 
not induce any significant response. 
(C) The dose-response curve of PACAP38-induced epolarization. 
Each data point represents averaged recordings from 3-5 fibers 
(mean _+ SEM). Resting potentials for all recordings are about -65 
to -80 inV. 
(D) Muscle response induced by ionophoretic perfusion of Na glu- 
tamate. 
ing for tens of seconds in response to a brief pressure- 
ejection of PACAP38 (4 I~M) via a micropipette (Figure 4). 
Such a time course is much slower than that seen with the 
focal application of glutamate, which induces a response 
lasting for a fraction of second (see Figure 3D; also see 
Jan and Jan, 1976b; Johansen et al., 1989). The prepara- 
tion was desensitized if a second dose of PACAP38 was 
applied within 1 min of a previous application (Figure 4A) 
or preincubation of the neuromuscular preparation with 2 
I~M PACAP38. Three muscle fibers were examined under 
Nomarski optics. We were able to localize some of large- 
sized varicosities (3-5 ~m in diameter) on muscle fiber 6 
(also see Johansen et al., 1989). Similar responses were 
recorded when 10 I*M PACAP38 was perfused on to the 
top of varicosity or 30 I~m away from the identified varicos- 
ity. This result suggests that the receptors that PACAP38 
binds to are not restricted to the region of neuromuscular 
junctions. 
After preincubation with its antiserum (1:200 dilution), 
PACAP38 lost its ability to depolarize the muscle mem- 
brane (Figure 4B), whereas mixing PACAP38 with antise- 
rum against PACAP27 did not abolish the PACAP38- 
induced response. In addition, 10 IIM VIP (Figure 4B) and 
glucagon (data not shown) did not induce any significant 
response. This evidence indicates the specificity of the 
response to PACAP38. 
The two-electrode voltage-clamp analysis showed that 
this depolarization results from an activation of an inward 
current (Figure 5A; see the second current trace in the 
top panel). In addition, the voltage-clamp analysis also 
revealed a second phase of this response: modulation of 
K + currents, which was not observed until minutes after 
the early depolarization. Muscle membrane currents were 
elicited by depolarizations to -50 mV (for monitoring leak- 
age current) and 0 mV from the holding potential of -80 
mV. A step to 0 mV elicits the voltage-activated inward Ca 2+ 
current and the voltage-activated and the Ca2+-activated 
outward K + currents (Singh and Wu, 1989; Zhong and Wu, 
1991b). However, the inward Ca 2+ current is completely 
masked by the outward K ÷ currents (Figure 5). Within the 
first 6 min after the application of PACAP38, the macro- 
scopic membrane currents were not altered appreciably 
as compared with the control. Then a dramatic enhance- 
ment of K ÷ currents was observed, and the increase 
reached its maximum after another 2 min. At its peak, the 
amplitude of the K ÷ currents was over 100 times larger 
than that recorded prior to the application of PACAP38. 
During the next 2-3 min, the amplitude of K ÷ currents grad- 
ually decreased to a magnitude similar to that in the con- 
trol. The whole process, beginning from the application 
of PACAP38 to complete recovery, took about 12 min in 
this particular example. This modulation altered not only 
the amplitude but also the kinetics and voltage-dependence 
of K ÷ currents (Figure 5B). 
The component modulated by PACAP38 appeared to 
be Ca 2÷ dependent, as suggested by the following obser- 
vation. The enhancement of K + currents was removed if 
the Ca 2÷ saline (1 mM Ca 2÷ and 20 mM Mg 2÷) was replaced 
by the Ca2+-free saline (20 mM Mg 2+) at the time that the 
enhancement of K ÷ currents induced by 4 IIM PACAP38 
reached almost to its maximum (data not shown). This 
enhancement would persist for another 2-4 min in the 
Ca 2+ saline. In addition to Ca 2÷- or voltage-activated K ÷ 
currents, the leakage current observed by a depolarization 
to -50 mV was also increased (comparing the current 
trace elicited by the -50 mV pulse in the control with that 
at 8' minute in Figure 5A), but the magnitude was relatively 
small, so that it is not apparent at the amplitude scale used 
in Figure 5. 
In a comparison with the response induced by perfusion 
of 4 I~M PACAP38 as presented above, the time interval 
between the early depolarization and the late enhance- 
ment of K ÷ current was much shorter if 10 ~M PACAP38 
was applied, occurring almost immediately after the early 
response. Conversely, the time interval became much 
longer if 1 pM PACAP38 was applied. 
To determine whether the enhancement of K ÷ currents 
is a result of electrical coupling between adjacent muscle 
fibers, depolarizing or hyperpolarizing-current pulses 
were injected into adjacent muscle fibers at various times 
following the application of PACAP38. The lack of re- 
sponse in muscle fibers to the injected current pulses ex- 
cluded the possibility of electrical coupling. To verify 
whether the late response is a secondary effect due to 
other factors released from the motor terminals, the motor- 
nerve axons were pulled away from the muscle fibers. 
Alternatively, tetrodotoxin (TTX; 1 ~g/ml), a Na ÷ channel 
blocker, was added to the bath saline at a concentration 
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Figure 5. PACAP38 Induced Late Enhance- 
ment of Voltage-Activated K + Currents 
(A) A typical time course of PACAP38 (4 p_M)- 
induced modulation of K ÷ currents recorded by 
voltage clamp. The command voltages are 
stepped from the holding potential of -80 to 
-50 and 0 mV respectively. Only a leakage cur- 
rent is elicited by the voltage step to -50 mV, 
but voltage-dependent currents are activated 
by depolarization to 0 mV. The bar indicates the 
pulse application of PACAP38, which activated 
an inward current when muscle membrane was 
clamped at -80 mV. At this voltage, the activa- 
tion of any voltage-activated currents is pre- 
vented (Singh and Wu, 1989; Zhong and Wu, 
1991), and it is also close to the reversal poten- 
tial of K ÷ channels. The inward current repre- 
sents the early response, which times the be- 
ginning (0') of the PACAP38 effect. The time 
in minutes after pressure-ejection ofPACAP38 
is indicated by each trace. 
(B) Current-voltage (I-V) relation of before and 
11 min after application of PACAP38. The I-V 
curve demonstrates the voltage dependence of 
the modulation. Over 20 fibers were analyzed. 
that abolishes any evoked transmitter release (Jan and 
Jan, 1976a; Wu et al., 1978; Ganetzky and Wu, 1983). In 
both situations, the PACAP38-induced modulation of K + 
currents was not affected. In addition, it was noted that 
the late response was induced almost simultaneously with 
the early response if 10 I~M PACAP38 was applied to a 
region far from the nerve terminal arborization. To prevent 
diffusion of PACAP38 towards nerve terminals, a constant 
saline exchange was maintained during recordings. These 
results support that PACAP38 itself may induce two tem- 
porally separated muscle responses: an early depolariza- 
tion and a late modulation of voltage-activated K + currents. 
Evoked PACAP-l ike Response 
If PACAP38-induced muscle responses reflect the func- 
tion of an endogenous neuropeptide, then similar re- 
sponses should be evoked by stimulation of the motor 
nerve axons. Recordings from muscle fiber 12 (n = 28) in 
19 larvae confirmed this possibility. As mentioned earlier, 
glutamate is the major excitatory neurotransmitter at the 
larval neuromuscular junction (Jan and Jan, 1976b; Jo- 
hansen et al., 1989). Each suprathreshold stimulation of 
the motor nerve fibers evoked glutamate-mediated excit- 
atory junction potentials (ejps) with a fast time course (milli- 
seconds). However, high frequency repetitive stimulation 
(20 Hz or higher) evoked not only fast ejps but also a 
5-15 mV slow depolarization lasting 5-10 s (Figure 6). 
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Figure 6. Evoked PACAP-like Slow Depolarization by High Frequency 
Stimulation of Motor Axons 
Top panel shows that 10 Hz electrical stimulation of the motor axons 
evokes fast ejps and a slow depolarization with saline containing 2 
mM Ca 2+. The slow depolarization is diminished by preincubation of 
the preparation with 2 ~M PACAP38 and the antiserum (1:40 dilution) 
against the vertebrate PACAP38. More than four fibers in each situa- 
tion have been examined. Recordings were obtained at least 10 min 
after the incubation. Bottom panel shows that argiotoxin, an open 
channel blocker of glutamate channels (Jackson and Usherwood, 
1988; Broadie and Betz, 1993), diminished fast ejps evoked by 20 Hz 
stimulation but not the slow depolarization. Resting potentials for these 
recordings are within -60 to -80 mV. Since the blockade of the fast 
ejps prevented massive muscle contraction, higher frequency stimula- 
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Figure 7. Evoked PACAP-like Enhancement 
of Voltage-Activated K* Currents by High Fre- 
quency Stimulation of Motor Axons 
The voltage paradigm is the same as that in 
Figure 3, and recordings were obtained only 
from muscle fiber 12. The time in minutes after 
stimulation is indicated by each trace. At 0 min, 
60 Hz stimulation of the motor axons evoked 
excitatory junctional currents. 
(A) A typical time course of evoked modulation 
of K + currents at I mM Ca 2+ concentration. The 
enhancement could be repeatedly induced. 
The interval between the early and late re- 
sponses is much shorter at 2 mM Ca 2+ concen- 
tration (data not shown), in over 20 muscle fi- 
bers examined, all were seen to respond to the 
40-80 Hz stimulation. 
(B) Preincubation of the muscle fibers with 0.4 
p.M PACAP38 abolished the evoked modula- 
tion. Incubation of PACAP38 itself induced an 
enhancement of K + currents several minutes 
later, after application. To see the desensitiza- 
tion effect, the 60 Hz stimulation was delivered 
after the PACAP38-induced enhancement had 
decayed (approximately 10 rain after incuba- 
tion with 0.4 laM PACAP38). The membrane 
currents were recorded every 1-2 min after the 
stimulation for up to 26 min. Since no obvious 
alteration was observed in any of these re- 
cordings, on ly current traces recorded at 1,10, 
and 20 rain are presented. As a control, the 2 
p.M VlP or glutamate appeared not to affect 
the evoked modulation (data not shown). Ten 
muscle fibers were examined. All ejps have the 
same scale as indicated in (B). 
mate-receptor channels (Jackson and Usherwood, 1988; 
Broadie and Betz, 1993), diminished the evoked fast ejps 
but not the slow depolarization (Figure 6). To exclude the 
possibility that the slow response might be induced by 
glutamate via activation of metabotropic receptors, which 
are not blocked by argiotoxin, (RS)-~-methyl-4-carboxphe- 
nylglycine (MCPG; 500 I~M), a metabotropic receptor 
blocker (Bashir et al., 1993), was added to the bath saline. 
MCPG did not affect the slow depolarization (data not 
shown). In addition, focal application of glutamate induced 
only a fast membrane depolarization (see Figure 5D) but 
no slow responses. This suggests that the evoked slow 
depolarization is probably not caused by glutamate re- 
lease. 
The time course of this evoked slow depolarization re- 
sembles the PACAP38-induced early response (see Fig- 
ure 4A). Furthermore, preincubation of the preparation 
with 2 ~M PACAP38 diminished the evoked slow depolar- 
ization (Figure 6). 
High frequency stimulation evoked not only the early 
slow depolarization but also a delayed enhancement of 
K + current. In response to 60 Hz stimulation, K + currents 
were not altered appreciably for the first 10 rain. Then, 
the amplitude of K ÷ currents was dramatical ly enhanced 
for about 1-3  min (Figure 7A). The time interval between 
the evoked early and late responses varied with the exter- 
nal Ca 2+ concentration in bath saline. The results pre- 
sented above were obtained with a 1 mM Ca 2÷ concentra- 
tion. When the Ca 2÷ concentration was increased to 2 raM, 
the time interval was drastically shortened to 47 _ 32 s 
(n -- 8) instead of 9 - 3.5 min (n = 8, at 1 mM Ca 2+) 
following the early response. It is possible that more neuro- 
peptide may be released at a higher Ca 2+ concentration 
in response to the same stimulation, thereby producing a 
faster response. 
Again, argiotoxin and MCPG, glutamate receptor block- 
ers, did not block the evoked enhancement of K + current. 
In addition, focal application of glutamate did not enhance 
muscle membrane K ÷ currents up to 30 rain later (data 
not shown). Therefore, the possibility of glutamate as a 
transmitter that induces the evoked slow depolarization 
(see above) and late modulation of K ÷ current is largely 
excluded. 
Preincubation of the preparation with 0.4 pM PACAP38 
abolished the high frequency- induced modulation of K ÷ 
currents at both 1 mM and 2 mM Ca 2÷ concentrations (Fig- 
ure 7B). However, preincubation of the preparation with 
either 0.4 ~M PACAP27 or 0.4 I~M VIP did not affect high 
frequency- induced modulation of K ÷ currents at 2 mM 
Ca 2÷ significantly. This evidence argues that an endoge- 
nous PACAP38-1ike peptide may be released from the mo- 
tor nerve terminals in response to high frequency stimu- 
lation. 
However, preincubation of the neuromuscular prepara- 
tions with anti-PACAP38 antiserum (1:100 dilution from 
the original) did not exert significant effect on the evoked 
slow depolarization and late enhancement of K ÷ currents. 
It has been shown in other systems that antibodies are 
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capable of blocking the effect of the application of a neuro- 
peptide but are ineffective in blocking the function of the 
same neuropeptide released endogenously (van Oers et 
al., 1992). This is probably due to the brief time available 
for formation of an antibody-neuropeptide complex during 
the releasing process. Before the formation of the com- 
plex, the released neuropeptide may already have reached 
the receptors on the postsynaptic membrane (about tens 
of milliseconds). 
Discussion 
PACAP-like Neuropeptide in Drosophila 
Existence of conserved neuropeptide families between 
vertebrates and invertebrates has been well documented 
(Josse, 1987). For instance, vasopressin and related pep- 
tides have been found in mammals, Mollusc, and insects 
(van Kesteren et al., 1992). In Drosophila, receptors ho- 
mologous to mammalian insulin or tachykinin receptors 
can be activated specifically by mammalian insulin, sub- 
stance P, and neuropeptide Y, respectively (Fernandez- 
Almonacid and Rosen, 1987; Li et al., 1991, 1992). Fur- 
thermore, insulin, substance P, and neuropeptide Y-like 
immunoreactivities revealed by vertebrate antibodies 
have also been found in Drosophila (Lundquist and N&s- 
eel, 1990). Therefore, it appears possible to use the verte- 
brate neuropeptide for characterizing the cellular function 
of its Drosophila counterpart. 
PACAP is an evolutionarily conserved neuropeptide 
among vertebrates. The amino acid sequence of PACAP38 
is identical among human, rat, and sheep, whereas only 
1 amino acid residue out of 38 is replaced in the frog (Ari- 
mura, 1992; Yon et al., 1992). Such conservation might 
well be extended into invertebrates. Evidence presented 
above supports this idea. 
First, PACAP38 can trigger a muscle response that is 
also evoked by high frequency stimulation of larval motor 
axons (see Figures 4-7). The requirement of high fre- 
quency stimulation to evoke the PACAP-like response is 
consistent with the idea that the released transmitters may 
be neuropeptides (Jan and Jan, 1982; Hokfelt, 1991). In 
addition, PACAP38 can desensitize the evoked PACAP- 
like response (Figure 6 and Figure 7), raising the possibility 
that PACAP38 and the released endogenous factors act 
on the same population of receptors. This physiological 
effect of PACAP38 appears to be rather specific. None of 
the neuropeptides proctolin, leucokinin I, and insulin are 
able to induce the PACAP38-1ike response (Y. Z., unpub- 
lished data), although immunoreactMties of these pep- 
tides have been detected at the larval nerve terminals (An- 
derson et al., 1988; Cantera and Nassel, 1992; Gorczyca 
et al., 1993). PACAP27 (5 ~M) is also unable to induce a 
PACAP38-1ike response. 
Second, PACAP38-1ike immunoreactivity is found at 
the neuromuscular junction (see Figure 2), where the 
PACAP38-1ike response can be evoked. This immunore- 
activity is seen along axons, in nerve terminal varicosities 
in the CNS, at neuromuscular junctions, and in the ring 
glands (data not shown), a tissue releasing various insect 
hormones (Riddiford, 1993). Such distribution is consis- 
tent with the idea that the PACAP38 antiserum may recog- 
nize a neuropeptide. This idea is reinforced by Western 
blot analysis. 
Third, Western blots not only identify PACAP38-immu- 
noreactive bands, but also a band that compares well with 
the PACAP38 band as the positive control (see Figure 3). 
In addition, it is interesting to note that the higher molecular 
weight PACAP38-immunoreactive band is in the range of 
the PACAP precursor protei n, having a calculated mass of 
19,450 Da (Arimura, 1992; see Figure 3). Taken together, 
functional, anatomical, and biochemical data corroborate 
that a PACAP38-1ike neuropeptide may function at Dro- 
sophila larval neuromuscular junctions. Further molecular 
or biochemical analyses are needed to determine the ex- 
act structure of the putative Drosophila PACAP. in fact, 
M. B. Feany has adduced genetic and molecular evidence 
that the amnesiac gene plausibly codes for a Drosophila 
pre-pro peptide product with homology to the PACAP neu- 
ropeptide (M. B. Feany and W. G. Quinn, personal commu- 
nication). 
Neuropeptide-Mediated Synaptic Transmission 
in Drosophila 
Application of PACAP38 induces two temporally distinct 
muscle responses. The nature of this response exhibits 
interesting characteristics, some of which have not been 
observed previously. The early inward current depolarizes 
the muscle membrane (see Figure 4 and Figure 6A), 
which, therefore, is excitatory in nature. In contrast, the 
late response, a strong enhancement of voltage-activated 
K + current, is inhibitory in nature. Since this voltage- 
dependent K ÷ current is activated at a membrane voltage 
of -20 mV or higher, the resting membrane potential (-60 
to -85 mV) appears not to be affected directly by the en- 
hancement of K ÷ current. However, it would be expected 
that generation of action potential in the muscle mem- 
brane may require greater synaptic input or the duration 
of the action potential may be shorter, owing to the en- 
hanced K ÷ currents (Hochner et al., 1986). 
Because similar responses can be evoked by a high 
frequency stimulation of motor axons and the evoked re- 
sponses can be desensitized by PACAP38, the PACAP38- 
induced responses may represent a physiological mode 
of neuropeptide action in Drosophila. The feature of this 
action is that the neuropeptide-gated slow excitatory syn- 
aptic transmission can be clearly separated from the same 
peptide-gated modulation of K ÷ currents (see Figure 6 and 
Figure 7). The time interval between these two responses 
can be as long as 15 min, and the duration appears to 
depend on the amount of the neuropeptide released. In 
addition, it is worth noting that the enhancement of volt- 
age-activated K ÷ currents can be as large as a 100-fold 
(see Figure 7). This K ÷ current may provide a model for 
studying mechanisms underlying the modulation of K ÷ cur- 
rents. 
Neurotransmitters such as acetylcholine and glutamate 
are capable of inducing synaptic transmission as well as 
modulation of K + currents at the same time (Charpak et al., 
1990). Similar responses are also observed in a number of 
neuropeptides, such as FMRFamide in Aplysia (Fisher et 
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al., 1993; Belk in and Abrams,  1993) and luteiniz ing hor- 
mone- re leas ing  hormone in frog sympathet ic  neurons  
( Jan and Jan,  1982; Bley and Tsien, 1987). However ,  it 
appears  that a complete  separat ion  of the onset  of  the late 
response  f rom the ear ly response  induced by the same 
neurot ransmit ter  has not been  expl ic i t ly examined in the 
prev ious  studies.  This initial analys is  of  PACAP38- induced 
and s t imulat ion-evoked musc le  responses  in Drosoph i la  
prov ides  a basis  for genet ic  d issect ion of neuropept ide-  
mediated synapt ic  t ransmiss ion.  
Experimental Procedures 
Electrophysiological Recordings 
The larval body-wall neuromuscular preparation has been described 
previously. Intracellular ecordings (Jan and Jan, 1976a; Wu et al., 
1978; Zhong and Wu, 1991a) and voltage-clamp analysis (Singh and 
Wu, 1989; Haugland and Wu, 1990; Zhong and Wu, 1991b, 1993) are 
similar to those described previously. In brief, third instar larvae from 
wild-type strain Canton S (raised at room temperature) were dissected 
in Ca2+-free saline that contained 70 mM NaCI, 5 mM KCI, 10 mM 
NaHCO3, 115 mM sucrose, 20 mM MgCIz, 5 mM trehalose, and 5 mM 
HEPES (buffered at pH 7.1). For recording, 2 mM CaCI~ was added 
to the saline in which large postsynaptic responses were evoked. How- 
ever, only 1 mM Ca 2+ was added in some of the voltage-clamp re- 
cordings for obtaining the current-voltage curve, which requires re- 
peated membrane depolarization. The lower Ca 2+ concentration allows 
better voltage clamping because of reduced muscle contraction. The 
saline used in this work differs from that used previously. The work 
done by Stewart et al. (unpublished data) has indicated that the new 
saline improves tability of the larval neuromuscular preparation. Elec- 
trical stimulation of motor nerve axons was applied by a suction elec- 
trode. For intracellular ecordings, data were taken by either camera 
directly from an oscilloscope or a chart recorder. For voltage-clamp 
experiments, data collection and analysis were performed using an 
Axoclamp 2A and a PC computer with pCLAMP software (version 5.05, 
Axons). Currents were filtered at 2 kHz and digitized at 4 kHz. Leakage 
currents were not subtracted in data presented to visualize the effects 
on both leakage currents and voltage-activated K + currents simultane- 
ously. All datawere obtained from muscle fibers 6 or 12 at room temper- 
ature (19°C-22°C). 
Application of Peptides, Glutamate, and Toxin 
Neuropeptides were applied by pressure ejection from a microelec- 
trode (1-5 ~m tip diameter) placed close to muscle membrane con- 
trolled by a syringe. The approximate region where the neuromuscular 
junctions reside on muscle fibers 6 and 12 are known from previous 
studies (Johansen et al., 1989; Bud nik et al., 1990; Zhong et al., 1993). 
The amount of neuropeptide jected for each test was so small that 
washing out was not required to see recovery of the peptide effect. 
PACAP38 and PACAP27 (Peninsula), VIP, and glucagon (Sigma) were 
dissolved in the bath saline (see above) at concentrations ranging from 
0.1 to 40 ~M. Na-glutamate (0.5 M; pH 8.0) was applied by ionto- 
phoresis (see Jan and Jan, 1976b; Johansen et al., 1989). Argiotoxin 
(1 I~M in the saline; Accurate Chemical) and MCPG (RBI) were deliv- 
ered by bath application. 
Immunohistochemistry 
Dissected larvae (Budnik et al., 1990; Zhong et al,, 1992) were fixed 
in nonalcoholic Bouin's solution (25 ml formalin, 5 ml glacial acetic 
acid, 75 ml saturated picric acid) for 1-2 hr. Then, the CNS and body- 
wall musculature were separated. The samples were incubated over- 
night at 4°C with anti-PACAP38 antiserum (RIN 8920, Peninsula) in 
0.1 M phosphate buffer (pH 7.2), 0.2% Triton X-lO0 (PBT) at 1:200 
for the neuromuscular preparation and at 1:400 for the CNS. After 
washing out the first antibody with PBT (3 times, 30 rain each), the 
musculature was incubated with 1:20 HRP-conjugated goat anti-rabbit 
IgG and the CNS with 1:400 fluorescein isothiocyanate-conjugated 
goat anti-rabbit IgG (Cappel). Staining of the neuromuscular prepara- 
tion was revealed by the HRP-catalyzed diaminobenzidine reaction, 
and staining of the CNS was observed by fluorescent microscopy. 
Another PACAP38 antiserum (IHC 8920, Peninsula) only weakly 
stained the Drosophila tissues. Antiserum against PACAP38 does not 
cross-react with VIP or even PACAP27. The same procedure was 
applied for anti-PACAP27 antisera, (RIN 8922 and IHC 8922, Penin- 
sula), but even when the concentration was raised to 10 times higher 
(1:40 dilution), the specific staining was not observed. For preabsorp- 
tion experiments, anti-PACAP38 antiserum was preabsorbed in 4 pM 
PACAP38 and 4 I~M PACAP27, respectively, in PBT at 4°C overnight 
and centrifuged at 16,000 x g. Then, the supernatant was incubated 
with the tissues. 
PACAP Extraction and Western Blot 
PACAP-like peptides were extracted from whole Drosophila larvae by 
two methods, essentially as described by Tatsuno et al. (1994), and 
by a standard ncnionic detergent cell lysis. Whole larvae (0,4-0,6 g) 
were homogenized in an A-type Dounce homogenizer with 1.5 ml of 
0.5 M acetic acid on ice. The homogenate was transferred to a micro- 
fuge tube and subsequently boiled for 15 min, quenched on ice, then 
centrifuged at 14,000 rpm for 30 rain at 4°C. The supernatant was 
injected onto a C18 Sep-Pak cartridge (Waters Associates), washed 
with water, and eluted stepwise with 1.5 ml each of 5%, 40%, and 
80% CH3CN/0.1% TFA. The eluates were frozen on a liquid N2 bath 
and lyophilized by a Speed-Vac Concentrator (Savant) until the vol- 
umes reached 50-100 ml. Alternatively, larvae were homogenized as 
above, but with a high salt, nonionic detergent lysis buffer instead. 
The lysis buffer (Harlow and Lane, 1988) was prepared with 50 mM 
Tris (pH 7.4), 500 mM NaCI, 10 mM EDTA, 10% glycerol, 1% Ncnidet 
P-40, 100 mg/ml Pefabloc-SC, 10 mg/ml leupeptin, 10 mg/ml soybean 
trypsin inhibitor, 10 mg/ml aprotinin, and 10 mg/ml TPCK (protease 
inhibitors from Boehringer-Mannheim). Aliquots of the homogenates 
and fractions were assayed for protein content using the BCA Assay 
(Pierce Chemical). To resolve low molecular weight proteins and pep- 
tides, samples were subjected to polyacrylamide gel electrophoresis 
using the Tris-Tricine gel and buffer system of Sh~iggar and Von Ja- 
gow (1987), but with reduced cross-linker (3%) for the separating gel. 
Purified synthetic PACAP27 and PACAP38 were loaded onto separate 
lanes as negative and positive controls, respectively. 
For Western blotting, wet transfer to polyvinylidene difluoride Im- 
mobilon-P membranes (Millipore) was done overnight at 60 V with 
Towbin Buffer (25 mM Tris, 192 mM glycine, 10% methanol) in a Hoofer 
Transphor tank (Hoefer Scientific Instruments) cooled with a Lauda 
refrigerated, circulating water bath (Brinkman Instruments). Blots were 
stained with Ponceau-S to confirm transfer of the smallest of broad- 
range molecular weight standards (New England Biolabs), blocked by 
incubating 1 hr in 5% nonfat dry milk, and rinsed 4 times with 20 mM 
Tris (pH 7.6), 137 m M NaCI, 2.6 mM KCI, and 0.1% Tween-20 between 
all steps. Blots were incubated 1 hr with anti-PACAP38 antiserum 
(RIN 8920, Peninsula) at a 1:20,000 dilution or with IgG purified fraction 
anti-PACAP38-1gG (IgG 8920, Peninsula) at a 1:7,500 dilution. Pri- 
mary antibody was detected by chemiluminescence with the ECL Kit 
(Amersham) according to the directions of the 
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